Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

Literature DB >> 23766531

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

Elizabeth A Williamson, Robert Hromas.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2013 PMID： 23766531 PMCID： PMC3699441 DOI： 10.1093/jnci/djt148

Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506

× No keyword cloud information.

15 in total

1. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense.

Authors: L A O'Neill; C A Dinarello
Journal: Immunol Today Date: 2000-05

2. The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors: J A Eaden; K R Abrams; J F Mayberry
Journal: Gut Date: 2001-04 Impact factor: 23.059

3. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.

Authors: B H Long; L Wang; A Lorico; R C Wang; M G Brattain; A M Casazza
Journal: Cancer Res Date: 1991-10-01 Impact factor: 12.701

4. Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation.

Authors: Isabelle Coste; Katy Le Corf; Alain Kfoury; Isabelle Hmitou; Sabine Druillennec; Pierre Hainaut; Alain Eychene; Serge Lebecque; Toufic Renno
Journal: J Clin Invest Date: 2010-10 Impact factor: 14.808

5. Mutational analysis of the human nucleotide excision repair gene ERCC1.

Authors: A M Sijbers; P J van der Spek; H Odijk; J van den Berg; M van Duin; A Westerveld; N G Jaspers; D Bootsma; J H Hoeijmakers
Journal: Nucleic Acids Res Date: 1996-09-01 Impact factor: 16.971

6. Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents.

Authors: Cha-Kyung Youn; Mi-Hwa Kim; Hyun-Ju Cho; Hong-Beum Kim; In-Youb Chang; Myung-Hee Chung; Ho Jin You
Journal: Cancer Res Date: 2004-07-15 Impact factor: 12.701

7. Colorectal cancer risk in Crohn's disease.

Authors: Hugh-James Freeman
Journal: World J Gastroenterol Date: 2008-03-28 Impact factor: 5.742

8. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks.

Authors: Laura J Niedernhofer; Hanny Odijk; Magda Budzowska; Ellen van Drunen; Alex Maas; Arjan F Theil; Jan de Wit; N G J Jaspers; H Berna Beverloo; Jan H J Hoeijmakers; Roland Kanaar
Journal: Mol Cell Biol Date: 2004-07 Impact factor: 4.272

Repressing DNA repair to enhance chemotherapy: targeting MyD88 in colon cancer.

1. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense.

2. The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

3. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.

4. Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation.

5. Mutational analysis of the human nucleotide excision repair gene ERCC1.

6. Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents.

7. Colorectal cancer risk in Crohn's disease.

8. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks.

9. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88.

Review 10. ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer.

1. A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma.

Review 2. The Role of TLRs in Anti-cancer Immunity and Tumor Rejection.